Tag: Arthritis: Rheumatoid
Four JAK Inhibitors Have Comparable Efficacy, Safety for RA
Baseline CRP, Clinical Disease Activity Index, glucocorticoid dose predict resistance to CDAI-low disease activity achievement
American College of Rheumatology, Nov. 10-15
ACR: Higher BMI Linked to Worse Flare Symptoms in Early RA
Patients with obesity had amplified impact of elevated BMI on RA-Flare Questionnaire scores compared with healthy weight, overweight
Oral Contraceptives May Protect Against Rheumatoid Arthritis
In contrast, use of menopausal hormone therapy may increase the risk for late-onset rheumatoid arthritis
Weight Gain, but No Increase in BP, Seen With Low-Dose Glucocorticoids in RA
Glucocorticoids led to 1.1 kg more weight gain than control treatment over two years using data from five pooled RCTs
Co-Occurrence of Psoriasis and Rheumatic Diseases Common
Psoriasis significantly linked to psoriatic arthritis, osteoarthritis, gout, fibromyalgia, RA, ankylosing spondylitis, Sjogren syndrome, systemic sclerosis
Rheumatoid Arthritis Tied to Higher Risk for Aortic Stenosis
Higher risk also seen for subsequent risks of undergoing aortic valve intervention and having aortic stenosis-related death
Prevalence of Neuropsychiatric Symptoms Up for Autoimmune Rheumatic Disease
More than 50 percent of those with systemic autoimmune rheumatic diseases had never/rarely reported mental health symptoms to clinicians
Treatment Effect of Tofacitinib, Adalimumab Compared in RA
Modest reduction seen in DAS28-CPR at three months for those receiving TOF versus ADA, but no difference seen at nine months
Peresolimab Found to Be Efficacious for Rheumatoid Arthritis
Change from baseline in Disease Activity Score for 28 joints based on the C-reactive protein level was significantly greater for 700 mg peresolimab versus placebo at week 12
